Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 467,172 | 362,931 | 413,464 | 396,781 | 331,817 |
| Cost of Goods | 91,691 | 44,545 | 50,559 | 44,176 | 37,026 |
| Gross Profit | 375,481 | 318,386 | 362,905 | 352,605 | 294,791 |
| Operating Expenses | 353,976 | 319,632 | 328,559 | 328,156 | 315,659 |
| Operating Income | 22,196 | -701 | 34,905 | 24,625 | -20,842 |
| Other Income | 11,810 | 14,278 | 6,543 | 15,746 | -12,332 |
| Pre-tax Income | 34,006 | 13,577 | 41,448 | 40,371 | -33,174 |
| Income Tax | 395 | 7,117 | 5,329 | -5,284 | 7,763 |
| Net Income Continuous | 33,611 | 6,460 | 36,119 | 45,655 | -40,937 |
| Net Income | $33,611 | $6,460 | $36,119 | $45,655 | $-40,937 |
| EPS Basic Total Ops | 0.35 | 0.07 | 0.38 | 0.79 | -0.46 |
| EPS Basic Continuous Ops | 0.35 | 0.07 | 0.38 | 0.79 | -0.46 |
| EPS Diluted Total Ops | 0.34 | 0.07 | 0.37 | 0.79 | -0.46 |
| EPS Diluted Continuous Ops | 0.33 | 0.07 | 0.36 | 0.79 | -0.46 |
| EPS Diluted Before Non-Recurring Items | 0.24 | 0.07 | 0.38 | N/A | N/A |
| EBITDA(a) | $21,387 | $-2,440 | $31,248 | $22,668 | $-22,516 |